0QF:ETR
Moderna Inc
168,53 €
arrow_upward
+0,23%(+0,39) 1D
5. lis, 11:26:50 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 0QF...
Otvori
169,74 €
Najviša
170,30 €
Najniža
167,84 €
Trž. kap.
75,86 mlr.
Prosj. kol.
31,26 tis.
Količina
5,68 tis.
52-tjed. najviša
184,20 €
52-tjed. najniža
19,37 €
Broj djelatnika
5 tis.
Otvori
169,74 €
Najviša
170,30 €
Najniža
167,84 €
Trž. kap.
75,86 mlr.
Prosj. kol.
31,26 tis.
Količina
5,68 tis.
52-tjed. najviša
184,20 €
52-tjed. najniža
19,37 €
Broj djelatnika
5 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
AD HOC NEWS
·
prije 3 sata
Moderna stock pre-market at EUR 170.25: plus 0.94 percent
Insider Monkey
·
prije 6 sati
Moderna (MRNA) Soars 175% in Q3: Can The Stock Keep Running?
GuruFocus
·
prije 15 sati
Moderna (MRNA) Shares Surge on Cancer Vaccine Optimism Despite C
TradingView
·
prije 16 sati
SA Asks: Is Moderna's stock now a sell after the recent run-up?
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Moderna Inc – informacije
Glavni izvršni direktorStéphane Bancel
Zaposlenici4,7 tis.
Osnovanoruj 2010
Sjedište-
Sektor-
Web-lokacijamodernatx.com